Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy.
Blood Adv
; 4(19): 4849-4859, 2020 10 13.
Article
in En
| MEDLINE
| ID: mdl-33031542
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Mantle-Cell
Type of study:
Prognostic_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Blood Adv
Year:
2020
Document type:
Article